AR073901A1 - Composicion topica farmaceutica, unguento y cremas que la comprende, y sus usos - Google Patents

Composicion topica farmaceutica, unguento y cremas que la comprende, y sus usos

Info

Publication number
AR073901A1
AR073901A1 ARP090104005A ARP090104005A AR073901A1 AR 073901 A1 AR073901 A1 AR 073901A1 AR P090104005 A ARP090104005 A AR P090104005A AR P090104005 A ARP090104005 A AR P090104005A AR 073901 A1 AR073901 A1 AR 073901A1
Authority
AR
Argentina
Prior art keywords
cream
incorporations
cream according
components
surfactants
Prior art date
Application number
ARP090104005A
Other languages
English (en)
Inventor
Antonio Guglietta
Cristina Tarrago
Manuel Raga
Benjamin Santos
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40291273&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR073901(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of AR073901A1 publication Critical patent/AR073901A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Reivindicacion 1: Una composicion farmacéutica topica semisolida y estable, caracterizada porque comprende entre 0,2 y 5% de la composicion de ozenoxacino, y un vehículo adecuado para elaborar un ungüento o una crema. Reivindicacion 4: Un ungüento conforme a la reivindicacion 3, caracterizado porque el vehículo adecuado es la parafina blanda blanca. Reivindicacion 6: Una crema conforme a la reivindicacion 5, caracterizada porque el vehículo incluye, en las proporciones consignadas a continuacion, como componentes de la crema: emulsificadores: 15-25%; preferentemente 18-22%; en particular 20%; surfactantes: 10-20%; preferentemente 13-15%; en particular 14%; componentes de aceite: 5-15%; preferentemente 7-9%; en particular 8%; ceras de bajo punto de fusion: 1-10%; preferiblemente 3-5%; en particular 4%; agua: 30-45%; preferentemente 35-40%; en particular 37,9%; componentes dispersables en agua: 10-20%; preferentemente 13-17%; en particular 15%; y conservantes que no donan formaldehído: 0,01-1% preferentemente 0,05-0,15%; en particular 0,1%. Reivindicacion 8: Una crema conforme a cualquiera de las incorporaciones 5 a 7, caracterizada porque los surfactantes son glicéridos poliglicolizados de ácidos oleicos. Reivindicacion 9: Una crema conforme a cualquiera de las incorporaciones 5 a 8, caracterizada porque el componente de aceite es el dodecanol 2-octil alcohol Guerbet. Reivindicacion 12: Una crema conforme a cualquiera de las incorporaciones 5 a 11, caracterizada porque el conservante que no dona formaldehído es el ácido benzoico.
ARP090104005A 2008-10-17 2009-10-19 Composicion topica farmaceutica, unguento y cremas que la comprende, y sus usos AR073901A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08166933A EP2177208A1 (en) 2008-10-17 2008-10-17 Pharmaceutical topical compositions

Publications (1)

Publication Number Publication Date
AR073901A1 true AR073901A1 (es) 2010-12-09

Family

ID=40291273

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090104005A AR073901A1 (es) 2008-10-17 2009-10-19 Composicion topica farmaceutica, unguento y cremas que la comprende, y sus usos

Country Status (24)

Country Link
US (4) US9180200B2 (es)
EP (3) EP2177208A1 (es)
JP (2) JP5509209B2 (es)
KR (3) KR20160025034A (es)
CN (1) CN102186460B (es)
AR (1) AR073901A1 (es)
AU (1) AU2009305360B2 (es)
BR (1) BRPI0920355B8 (es)
CA (2) CA2738384C (es)
CL (2) CL2011000848A1 (es)
CY (1) CY1114838T1 (es)
DK (1) DK2344130T3 (es)
ES (1) ES2437967T3 (es)
HK (1) HK1161552A1 (es)
MX (2) MX338029B (es)
NL (1) NL300884I2 (es)
PH (1) PH12014502425A1 (es)
PL (1) PL2344130T3 (es)
PT (1) PT2344130E (es)
RU (1) RU2478367C2 (es)
SI (1) SI2344130T1 (es)
TW (2) TW201511779A (es)
UY (1) UY32187A (es)
WO (1) WO2010043717A2 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130102460A (ko) * 2010-05-10 2013-09-17 세게티스, 인코포레이티드. 알킬 케탈 에스터를 함유하는 퍼스널 케어 조제물 및 제조방법
WO2014047428A1 (en) 2012-09-21 2014-03-27 Segetis, Inc. Cleaning, surfactant, and personal care compositions
DE102013226507B4 (de) 2013-12-18 2022-05-05 Ashland Industries Europe Gmbh Konzentrat umfassend Ferulasäureethylester und Arylalkanol und dessen Verwendung
ES2970434T3 (es) 2014-09-12 2024-05-28 Union Therapeutics As Uso antibacteriano de salicilanilidas halogenadas
JP6775869B2 (ja) * 2015-02-13 2020-10-28 マルホ株式会社 ピリドンカルボン酸系誘導体を含有する外用剤
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
GB201604484D0 (en) 2016-03-16 2016-04-27 Antibiotx Aps And Københavns Uni University Of Copenhagen Topical antibacterial compositions
JP7347915B2 (ja) * 2016-04-28 2023-09-20 マルホ株式会社 抗菌剤
WO2018048042A1 (ko) * 2016-09-12 2018-03-15 주식회사 가나씨앤에이치 글리세린 젖산 에스테르를 유효성분으로 하는 방부 및 항균용 외용제 조성물
CN110035755A (zh) * 2016-12-01 2019-07-19 玛路弘株式会社 医疗用皮肤外用剂
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide
CN113712913A (zh) * 2020-05-25 2021-11-30 南京帝昌医药科技有限公司 一种奥泽沙星混悬滴眼液组合物
US11724077B2 (en) * 2021-07-28 2023-08-15 Subhash Dhawan Therapeutic swabs for treating upper respiratory infections

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04243827A (ja) * 1991-01-25 1992-08-31 Sumitomo Pharmaceut Co Ltd プロスタグランジン誘導体含有溶解型軟膏剤
JP3174590B2 (ja) * 1991-04-04 2001-06-11 テルモ株式会社 ステロイド軟膏剤
FR2728166A1 (fr) * 1994-12-19 1996-06-21 Oreal Composition topique contenant un antagoniste de substance p
JP3162335B2 (ja) * 1998-03-11 2001-04-25 ユーナイテッド ネイションズ デベロップメント プログラム 皮膚真菌感染症治療用の植物薬剤、その製造法と用途
EP1070713B1 (en) 1998-04-06 2006-10-18 Toyama Chemical Co., Ltd. Quinolonecarboxylic acid derivatives or salts thereof
ES2233383T3 (es) * 1999-06-08 2005-06-16 Lorantis Limited Utilizacion terapeutica de un ihibidor de la via de señalizacion hedgehog.
JP4293755B2 (ja) 2001-03-26 2009-07-08 富山化学工業株式会社 ピリドンカルボン酸系化合物を含有する皮膚外用剤
JP4384402B2 (ja) 2001-11-30 2009-12-16 富山化学工業株式会社 デスフルオロピリドンカルボン酸系化合物を含有する水溶液剤およびその粉末化物並びにそれら製造方法
HUE028288T2 (en) 2004-03-31 2016-12-28 Toyama Chemical Co Ltd A fine dispersion of a low solubility drug and a process for producing it
EP1698336A1 (en) * 2005-03-01 2006-09-06 Ferrer Internacional, S.A. Antifungal compositions comprising Sertaconazole and either Hydrocortisone or an antibacterial agent
KR101245960B1 (ko) * 2005-08-01 2013-03-21 마루호 코 엘티디 피리돈카르복시산 유도체를 함유하는 로션제
JP5112669B2 (ja) 2005-09-30 2013-01-09 富山化学工業株式会社 難溶性薬物のナノ微粒子を含有する水性懸濁液剤

Also Published As

Publication number Publication date
TW201018497A (en) 2010-05-16
WO2010043717A3 (en) 2010-07-29
RU2478367C2 (ru) 2013-04-10
KR20160025034A (ko) 2016-03-07
HK1161552A1 (en) 2012-07-27
ES2437967T3 (es) 2014-01-15
CA2738384C (en) 2014-07-08
CA2822167C (en) 2015-09-01
PH12014502425A1 (en) 2015-09-07
AU2009305360B2 (en) 2015-04-09
KR20110071086A (ko) 2011-06-28
EP2177208A1 (en) 2010-04-21
MX2011004052A (es) 2011-05-10
BRPI0920355B1 (pt) 2020-04-07
US20140187578A1 (en) 2014-07-03
JP2014088456A (ja) 2014-05-15
US9180200B2 (en) 2015-11-10
US20160243104A1 (en) 2016-08-25
US20160030338A1 (en) 2016-02-04
CN102186460B (zh) 2013-06-12
EP2344130A2 (en) 2011-07-20
MX338029B (es) 2016-03-31
EP2344130B9 (en) 2013-11-20
JP5509209B2 (ja) 2014-06-04
KR20160116353A (ko) 2016-10-07
CY1114838T1 (el) 2016-12-14
US10022363B2 (en) 2018-07-17
UY32187A (es) 2010-04-30
AU2009305360A1 (en) 2010-04-22
CA2822167A1 (en) 2010-04-22
CL2011000848A1 (es) 2012-03-30
NL300884I2 (nl) 2017-08-31
TW201511779A (zh) 2015-04-01
SI2344130T1 (sl) 2013-12-31
PT2344130E (pt) 2013-12-09
RU2011119764A (ru) 2012-11-27
JP5873120B2 (ja) 2016-03-01
EP2344130B1 (en) 2013-09-04
PL2344130T3 (pl) 2014-03-31
BRPI0920355A2 (pt) 2016-03-15
CL2015002899A1 (es) 2016-05-13
KR101682256B1 (ko) 2016-12-02
US9399014B2 (en) 2016-07-26
DK2344130T3 (da) 2013-12-09
CN102186460A (zh) 2011-09-14
WO2010043717A2 (en) 2010-04-22
EP2570117A1 (en) 2013-03-20
TWI504418B (zh) 2015-10-21
US20110263646A1 (en) 2011-10-27
BRPI0920355B8 (pt) 2021-05-25
CA2738384A1 (en) 2010-04-22
JP2012505867A (ja) 2012-03-08

Similar Documents

Publication Publication Date Title
AR073901A1 (es) Composicion topica farmaceutica, unguento y cremas que la comprende, y sus usos
ES2524320T3 (es) Composición para la prevención o el tratamiento de enfermedad asociada con trombo o émbolo
AR113034A2 (es) Formulación líquida de un conjugado de la hormona del crecimiento humano de efecto prolongado
CO6220926A2 (es) Formulacion farmaceutica topica para la aplicacion de un farmaco antiinflamatorio no esferoidal (nsaid)
AR051420A1 (es) Procesos para la preparacion de composiciones oleosas
CY1120888T1 (el) Διαδερμικες φαρμακευτικες συνθεσεις περιλαμβανοντας ενεργους παραγοντες
AR070122A1 (es) Composicion de limpieza de bajos residuos
ECSP10010433A (es) Composición que comprende anticuerpo que se fija al dominio ii de her2, y sus variantes ácidas
PE20110449A1 (es) Emulsiones modificadas de liberacion de medicina para aplicacion a la piel o la mucosa vaginal
NI201200038A (es) Conjugados de niacina y ácidos grasos y sus usos
RU2010114233A (ru) Применение гидрофобин-полипептидов в качестве усилителя пенетрации
PE20142367A1 (es) Formulaciones de imiquimod
CO6270203A2 (es) Una solucion topica no acuosa novedosa de diclofenaco y el proceso para preparar la misma
BRPI0912290A8 (pt) Detergentes para pele e mãos.
CO6390034A2 (es) Uso de una composición espumable esencialmente libre de ingredientes con actividad farmacéutica para el tratamiento de la piel humana
CO6541537A2 (es) Composición para el cuidado personal que proporciona mejora de suavidad y silencio y articulos usnado la misma
BR112013020167A2 (pt) melhoradores de permeação para formulações tópicas
WO2013144260A3 (en) Composition comprising (2,5-diaminophenyl)ethanol, an alkylpolyglucoside nonionic surfactant, an oxyethylenated sorbitan ester or a polyalkoxylated or polyglycerolated fatty alcohol in a medium rich in fatty substances, dyeing process and device therefore
RU2010103038A (ru) Композиции для персонального ухода, обладающие ослабленным раздражающим действием на глаза
PE20110330A1 (es) Composicion topica para el tratamiento de queratosis actinica
PE20151044A1 (es) Retiro de componentes indeseados de las composiciones de aceite
IN2014DN05640A (es)
WO2013004773A3 (en) Cosmetic composition rich in fatty substances comprising a polyoxyalkylenated fatty alcohol ether and a direct dye and/or an oxidation dye, the dyeing method and the device
ES2497667T3 (es) Sistema de emulsificación para usar en cosméticos
BRPI0900822A2 (pt) composição em forma de emulsão óleo-em-água e processo não terapêutico

Legal Events

Date Code Title Description
FB Suspension of granting procedure